Product Images Cilostazol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Cilostazol NDC 0093-2064 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure for Cilostazol - image 1
figure1 - image 2
This is a chart showing the plasma concentration (in ng/mL) of cilostazol and its metabolites over time (in hours). There are three substances being measured: cilostazol, 3,4-dehydrocilostazol, and 4'-trans-hydroxycilostazol. The chart displays values at 12, 16, 20, and 24 hours.*
figure 2 - image 3
Percent Mean Improvement in Maximal Walking Distance for patients treated with Cilostazol 50 mg and Cilostazol 100 mg b.i.d. The data is presented in a graph with 3 different durations of treatment: 24 weeks, 16 weeks, and 12 weeks.*
image - image 4
This is a medication information leaflet for Cilostazol Tablets USP containing 50mg cilostazol. It indicates that the usual dosage is 1 tablet and advises keeping the medication out of reach of children. The leaflet provides the drug code, recommends dispensing with the attached patient information leaflet, and mentions a resistant closure on the packaging. All the other text is either identification numbers and dates or illegible.*
image - image 5
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.